Trial
NCT00895648
Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University Health Network, Toronto
Collaborators
Eli Lilly and Company
Condition
Mesothelioma
Intervention
Pemetrexed
Why stopped
low accrual due to competing study for same group of patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-04